e-learning
resources
Milan 2017
Sunday, 10.09.2017
Novel mechanisms in asthma
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Proteomics analysis of asthma biomarkers: proxima sub-study
P. Mauri (SEGRATE (MI), Italy)
Source:
International Congress 2017 – Novel mechanisms in asthma
Session:
Novel mechanisms in asthma
Session type:
Thematic Poster
Number:
1163
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
P. Mauri (SEGRATE (MI), Italy). Proteomics analysis of asthma biomarkers: proxima sub-study. 1163
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Related content which might interest you:
Metabolomic analysis of severe COPD. Study of biomarkers in the CHAIN cohort.
Source: International Congress 2019 – New molecular signatures in COPD, lung cancer and a1-antitrypsin deficiency
Year: 2019
Proteome fingerprints define groups with distinct clinico-pathological phenotypes in the U-BIOPRED asthma study
Source: International Congress 2016 – What's new in biomarker analysis?
Year: 2016
Novel proteomic biomarkers in the evaluation of childhood asthma
Source: Annual Congress 2013 –Monitoring asthma: genes, cells and molecules
Year: 2013
ADEPT, airway disease endotyping for personalized treatment: Interim analysis of asthma patients
Source: Annual Congress 2013 –Novel drugs and biomarkers in respiratory medicine
Year: 2013
Plasma metabolomic signature in COPD patients: Associations to proteomic profile and clinical outcomes
Source: Annual Congress 2013 –COPD mechanisms
Year: 2013
Parametric response mapping of COPD phenotypes: A COPDGene study
Source: International Congress 2015 – CT, PET, MRI modalities: fusion of anatomical and functional variables for lung assessment
Year: 2015
Whole transcriptome analysis in peripheral blood from asthmatic and healthy subjects in the U-BIOPRED study
Source: International Congress 2014 – Molecular pathogenesis of pulmonary inflammatory diseases (COPD, asthma and ILD)
Year: 2014
High-throughput analysis of induced sputum from the U-BIOPRED study using novel proteomic and data mining approaches
Source: Annual Congress 2013 –Origins and diagnosis of asthma
Year: 2013
Altered serum metabolomics in COPD: analysis of the SPIROMICS cohort
Source: International Congress 2018 – COPD phenotypes: a1 antitrypsin deficiency and beyond
Year: 2018
Cluster analysis on longitudinal data of patients with adult-onset asthma
Source: International Congress 2016 – Asthma: from basic mechanisms to novel therapeutic perspectives
Year: 2016
A CADSET WP4 transcriptomic analysis of Asthma and COPD overlap
Source: Virtual Congress 2020 – Asthma science: novel targets and mechanisms
Year: 2020
Identification and analysis of clinical phenotypes in COPD patients: PALOMB Cohort
Source: Virtual Congress 2021 – COPD burden, epidemiology and management
Year: 2021
Multivariate cluster analysis of immunopathological and clinical data from the U-BIOPRED severe asthma study: Preliminary results
Source: International Congress 2015 – New insights into lung disease pathogenesis
Year: 2015
Unbiased cluster analysis of severe asthma based on metabolomics by the U-BIOPRED electronic nose platform
Source: Annual Congress 2013 –Asthma and COPD: diseases with different phenotypes
Year: 2013
Observational study to characterise 24-hour COPD symptoms: Interim analysis of ASSESS
Source: Annual Congress 2013 –Monitoring symptoms and quality of life
Year: 2013
Transcriptome analysis of controlled and problematic severe childhood asthma
Source: Annual Congress 2013 –Uncontrolled and severe asthma in children
Year: 2013
Late Breaking Abstract - Longitudinal analysis of variation in clinical features from the U-BIOPRED severe asthma cohort
Source: International Congress 2018 – Notable Studies in Asthma
Year: 2018
Bronchial asthma (BA) pharmacogenetic profile and therapeutic resistance in slavic population
Source: Annual Congress 2013 –Is it really asthma?
Year: 2013
Metabolomic profiling differences among asthma, COPD and healthy controls: a LC-MS-based metabolomics analysis
Source: International Congress 2019 – Evaluation of basic science in airway diseases
Year: 2019
Environment and lung function in adults with asthma: an exposome approach in the EGEA study
Source: International Congress 2019 – Air pollution: from early life, the home environment to going underground
Year: 2019
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept